Osteoporosis drug Prolia faces intense competition as patents expire and generics launch Intense rivalry emerges in the ...
With Keytruda, the best-selling drug in the world, facing the end of exclusivity in 2028, BioSpace looks at five drugs that ...
Basically, a brand-name drug company settles a patent infringement lawsuit by paying cash or transferring something else of ...
On March 13, 2025, the Federal Circuit decided in Merck Sharp & Dohme B.V. v. Aurobindo Pharma USA, Inc. (No. 2023-2254) how ...
The Print on MSN14h
How reciprocal Trump tariffs may impact Indian pharma, and become a bitter pill for the USSpooked by US president's threat, several Indian pharma players lobby for blanket duty waiver on drugs coming from America, ...
A generic product cannot enter the market until the originator product’s IP has expired, but the development process can take ...
Generic drugmakers and hospital pharmacists warn that added financial pressure from tariffs could strain the nation's generic drug supplies.
Even as Novartis takes home a partial win in court tied to its key blockbuster Entresto, the Swiss drugmaker continues to ...
Swiss pharma major Novartis (NOVN: VX) is set to lay off 427 employees at its East Hanover, New Jersey, site as part of a ...
Empagliflozin patent expiration in India leads to affordable treatment for diabetes, heart failure, and kidney disease.
Both generic and innovator companies have tried to understand the ways in which prices change once a patent has expired and a generic product launched. Generic companies have to plan their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback